KLK3 and cancer: The Prostate Health Index (PHI; a combination of tPSA, fPSA, and proPSA) was noted to have approximately double the sensitivity of fPSA/tPSA for cancer detection in those with serum PSA concentrations between 2.0 and 10.0 ng/mL.